Beijing Succeeder Technology Inc. (SHA:688338)
China · Delayed Price · Currency is CNY 32.55
-0.60 (-1.81%)
At close: Feb 13, 2026
SHA:688338 Revenue
In the year 2025, Beijing Succeeder Technology had annual revenue of 263.67M CNY, down -13.80%. Beijing Succeeder Technology had revenue of 67.99M in the quarter ending December 31, 2025, a decrease of -14.31%.
Revenue
263.67M
Revenue Growth
-13.80%
P/S Ratio
12.84
Revenue / Employee
948.45K
Employees
274
Market Cap
3.38B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 263.67M | -42.20M | -13.80% |
| Dec 31, 2024 | 305.87M | 30.38M | 11.03% |
| Dec 31, 2023 | 275.49M | 46.67M | 20.40% |
| Dec 31, 2022 | 228.81M | -11.10M | -4.63% |
| Dec 31, 2021 | 239.92M | 17.52M | 7.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Kehua Bio-Engineering Co.,Ltd | 1.60B |
| Guangdong Biolight Meditech | 1.05B |
| Guangdong Transtek Medical Electronics | 984.77M |
| Dirui Industrial | 511.11M |
| Shanghai General Healthy Information and Technology | 393.61M |
| Tellgen | 373.48M |
| Beijing Leadman Biochemistry | 340.65M |
| Kontour (Xi'an) Medical Technology | 332.92M |